CVS Health Corporation
CVS
$78.15
$1.461.90%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 391.69B | 384.33B | 376.74B | 370.66B | 367.25B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 391.69B | 384.33B | 376.74B | 370.66B | 367.25B |
| Cost of Revenue | 339.39B | 333.20B | 325.72B | 321.41B | 316.53B |
| Gross Profit | 52.30B | 51.13B | 51.02B | 49.25B | 50.71B |
| SG&A Expenses | 42.36B | 41.68B | 41.57B | 41.11B | 41.04B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 381.75B | 374.87B | 367.29B | 362.52B | 357.57B |
| Operating Income | 9.94B | 9.46B | 9.45B | 8.14B | 9.68B |
| Income Before Tax | 2.91B | 6.50B | 7.19B | 6.15B | 6.73B |
| Income Tax Expenses | 2.48B | 2.01B | 1.94B | 1.56B | 1.72B |
| Earnings from Continuing Operations | 428.00 | 4.49K | 5.24K | 4.59K | 5.01K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 41.00M | 42.00M | 36.00M | 28.00M | 6.00M |
| Net Income | 469.00M | 4.53B | 5.28B | 4.61B | 5.02B |
| EBIT | 9.94B | 9.46B | 9.45B | 8.14B | 9.68B |
| EBITDA | 14.55B | 14.09B | 14.06B | 12.73B | 14.26B |
| EPS Basic | 0.39 | 3.59 | 4.19 | 3.67 | 3.95 |
| Normalized Basic EPS | 4.61 | 4.35 | 4.32 | 3.66 | 4.17 |
| EPS Diluted | 0.38 | 3.58 | 4.19 | 3.66 | 3.95 |
| Normalized Diluted EPS | 4.60 | 4.34 | 4.31 | 3.65 | 4.16 |
| Average Basic Shares Outstanding | 5.06B | 5.05B | 5.04B | 5.03B | 5.06B |
| Average Diluted Shares Outstanding | 5.06B | 5.05B | 5.04B | 5.05B | 5.08B |
| Dividend Per Share | 2.66 | 2.66 | 2.66 | 2.66 | 2.60 |
| Payout Ratio | 722.81% | 74.62% | 63.88% | 73.10% | 66.07% |